Metraipolis › archive › dc_6975639828dc
HDAC3 inhibition as a therapeutic strategy in T-cell acute lymphoblastic leukemia via the TYK2-STAT1-BCL2 signaling pathway — Europe PMC PMID:41716392
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41716392
- DOI
- 10.3389/fimmu.2026.1752727
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T03:36:19.869Z
- SHA-256 of the archived text
e4f4a7f573fb155421b78cafb50748abff6e898787e1160d3ac788f883ca064b- Stable URL of this page
https://metraipolis.com/documento/dc_6975639828dc
How to cite
HDAC3 inhibition as a therapeutic strategy in T-cell acute lymphoblastic leukemia via the TYK2-STAT1-BCL2 signaling pathway — Europe PMC PMID:41716392 — Europe PMC (en), https://europepmc.org/article/MED/41716392 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6975639828dc (Metraipolis archive dc_6975639828dc, sha256 e4f4a7f573fb155421b78cafb50748abff6e898787e1160d3ac788f883ca064b)
BibTeX
@misc{dc6975639828dc,
title = {HDAC3 inhibition as a therapeutic strategy in T-cell acute lymphoblastic leukemia via the TYK2-STAT1-BCL2 signaling pathway — Europe PMC PMID:41716392},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41716392},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6975639828dc; sha256 e4f4a7f573fb155421b78cafb50748abff6e898787e1160d3ac788f883ca064b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41716392. Agents can read the archived copy with the MCP tool read_document.